Theralase Technologies Inc.

TSXV:TLT Stock Report

Market Cap: CA$41.3m

Theralase Technologies Management

Management criteria checks 2/4

Theralase Technologies' CEO is Roger Dumoulin-White, appointed in May 2023, has a tenure of 1.17 years. total yearly compensation is CA$405.00K, comprised of 98.8% salary and 1.2% bonuses, including company stock and options. directly owns 4.73% of the company’s shares, worth CA$1.95M. The average tenure of the management team and the board of directors is 13.9 years and 6.1 years respectively.

Key information

Roger Dumoulin-White

Chief executive officer

CA$405.0k

Total compensation

CEO salary percentage98.8%
CEO tenure1.2yrs
CEO ownership4.7%
Management average tenure13.9yrs
Board average tenure6.1yrs

Recent management updates

Recent updates

Is Theralase Technologies (CVE:TLT) In A Good Position To Deliver On Growth Plans?

Jul 29
Is Theralase Technologies (CVE:TLT) In A Good Position To Deliver On Growth Plans?

We're Not Very Worried About Theralase Technologies' (CVE:TLT) Cash Burn Rate

Apr 08
We're Not Very Worried About Theralase Technologies' (CVE:TLT) Cash Burn Rate

Here's Why We're Not Too Worried About Theralase Technologies' (CVE:TLT) Cash Burn Situation

Dec 24
Here's Why We're Not Too Worried About Theralase Technologies' (CVE:TLT) Cash Burn Situation

Here's Why We're Not Too Worried About Theralase Technologies' (CVE:TLT) Cash Burn Situation

Sep 03
Here's Why We're Not Too Worried About Theralase Technologies' (CVE:TLT) Cash Burn Situation

We Think Theralase Technologies (CVE:TLT) Can Afford To Drive Business Growth

May 13
We Think Theralase Technologies (CVE:TLT) Can Afford To Drive Business Growth

CEO Compensation Analysis

How has Roger Dumoulin-White's remuneration changed compared to Theralase Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-CA$4m

Dec 31 2023CA$405kCA$400k

-CA$5m

Sep 30 2023n/an/a

-CA$4m

Jun 30 2023n/an/a

-CA$5m

Mar 31 2023n/an/a

-CA$5m

Dec 31 2022n/an/a

-CA$5m

Sep 30 2022n/an/a

-CA$6m

Jun 30 2022n/an/a

-CA$5m

Mar 31 2022n/an/a

-CA$5m

Dec 31 2021n/an/a

-CA$4m

Sep 30 2021n/an/a

-CA$4m

Jun 30 2021n/an/a

-CA$4m

Mar 31 2021n/an/a

-CA$5m

Dec 31 2020n/an/a

-CA$6m

Sep 30 2020n/an/a

-CA$8m

Jun 30 2020n/an/a

-CA$8m

Mar 31 2020n/an/a

-CA$8m

Dec 31 2019n/an/a

-CA$7m

Sep 30 2019n/an/a

-CA$5m

Jun 30 2019n/an/a

-CA$4m

Mar 31 2019n/an/a

-CA$3m

Dec 31 2018CA$301kCA$300k

-CA$3m

Sep 30 2018n/an/a

-CA$4m

Jun 30 2018n/an/a

-CA$5m

Mar 31 2018n/an/a

-CA$6m

Dec 31 2017CA$734kCA$300k

-CA$6m

Compensation vs Market: Roger's total compensation ($USD292.34K) is above average for companies of similar size in the Canadian market ($USD173.24K).

Compensation vs Earnings: Roger's compensation has increased whilst the company is unprofitable.

CEO

Roger Dumoulin-White

1.2yrs

Tenure

CA$405,000

Compensation

Mr. Roger John Dumoulin-White, B.Sc., P.Eng., Pro. Dir., is President, Chief Executive Officer and Director of Theralase Technologies Inc. from May 2023. He joined the Theralase Technologies Inc. in 2003....

Leadership Team

NamePositionTenureCompensationOwnership
Roger Dumoulin-White
President1.2yrsCA$405.00k4.73%
CA$ 2.0m
Kristina Hachey
CFO & Director20.2yrsCA$260.00k1.25%
CA$ 515.8k
Arkady Mandel
Chief Scientific Officer & Director13.4yrsCA$310.00k0.12%
CA$ 50.8k
David Groves
President of World Trade Division17.7yrsno datano data
Terry Ruch
Equine Medical Consultant13.9yrsno datano data

13.9yrs

Average Tenure

Experienced Management: TLT's management team is seasoned and experienced (13.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Roger Dumoulin-White
President1.2yrsCA$405.00k4.73%
CA$ 2.0m
Kristina Hachey
CFO & Director5.1yrsCA$260.00k1.25%
CA$ 515.8k
Arkady Mandel
Chief Scientific Officer & Director6.1yrsCA$310.00k0.12%
CA$ 50.8k
Randy Bruder
Independent Director16.5yrsCA$10.00k0.77%
CA$ 317.6k
Matthew Perraton
Independent Chairman of the Board11.4yrsCA$10.00k0.021%
CA$ 8.7k
Guy Anderson
Independent Director11.4yrsCA$10.00k0.092%
CA$ 38.0k
Ashish Kamat
Member of Medical & Scientific Advisory Board9.6yrsno datano data
Michael O'Donnell
Member of Medical & Scientific Advisory Board1.5yrsno datano data
Kaouthar Lbiati
Independent Director1.1yrsCA$45.13k0.0041%
CA$ 1.7k

6.1yrs

Average Tenure

Experienced Board: TLT's board of directors are considered experienced (6.1 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.